Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,820.00p
   
  • Change Today:
    -4.00p
  • 52 Week High: 2,506.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 35,111
  • Market Cap: £1,201.80m
  • RiskGrade: 128

Latest ShareCast News

Genus holds gloomy guidance as tough conditions persist

By Benjamin Chiou

Date: Thursday 22 Feb 2024

(Sharecast News) - There were few surprises in Genus's interim results on Thursday after a detailed trading update from the animal genetics company just last week, as it reported a 31% drop in adjusted profits as expected.

London close: Stocks manage gains despite UK recession news

By Josh White

Date: Thursday 15 Feb 2024

(Sharecast News) - London markets had a mixed but ultimately positive day of trading on Thursday, despite news that the UK fell into a technical recession at the end of 2023.

Genus tumbles after warning on full-year profits

By Michele Maatouk

Date: Thursday 15 Feb 2024

(Sharecast News) - Genus shares tumbled on Thursday as the animal genetics company warned on full-year profits.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,820.00p
Change Today -4.00p
% Change -0.22 %
52 Week High 2,506.00
52 Week Low 1,637.00
Volume 35,111
Shares Issued 66.03m
Market Cap £1,201.80m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.52% below the market average95.52% below the market average95.52% below the market average95.52% below the market average95.52% below the market average
96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average
Price Trend
55.98% below the market average55.98% below the market average55.98% below the market average55.98% below the market average55.98% below the market average
9.43% above the sector average9.43% above the sector average9.43% above the sector average9.43% above the sector average9.43% above the sector average
Income
83.33% below the market average83.33% below the market average83.33% below the market average83.33% below the market average83.33% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
66.43% below the market average66.43% below the market average66.43% below the market average66.43% below the market average66.43% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 07-Jun-2024

Time Volume / Share Price
16:35 18,618 @ 1,820.00p
16:35 116 @ 1,820.00p
16:35 4 @ 1,820.00p
16:35 91 @ 1,820.00p
16:35 284 @ 1,820.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page